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Hyaluronic acid hydrogel for controlled self-renewal and differentiation of
human embryonic stem cells
Abstract
Control of self-renewal and differentiation of human ES cells (hESCs) remains a challenge. This is largely due
to the use of culture systems that involve poorly defined animal products and do not mimic the normal
developmental milieu. Routine protocols involve the propagation of hESCs on mouse fibroblast or human
feeder layers, enzymatic cell removal, and spontaneous differentiation in cultures of embryoid bodies, and
each of these steps involves significant variability of culture conditions. We report that a completely synthetic
hydrogel matrix can support (i) long-term self-renewal of hESCs in the presence of conditioned medium from
mouse embryonic fibroblast feeder layers, and (ii) direct cell differentiation. Hyaluronic acid (HA) hydrogels
were selected because of the role of HA in early development and feeder layer cultures of hESCs and the
controllability of hydrogel architecture, mechanics, and degradation. When encapsulated in 3D HA hydrogels
(but not within other hydrogels or in monolayer cultures on HA), hESCs maintained their undifferentiated
state, preserved their normal karyotype, and maintained their full differentiation capacity as indicated by
embryoid body formation. Differentiation could be induced within the same hydrogel by simply altering
soluble factors. We therefore propose that HA hydrogels, with their developmentally relevant composition
and tunable physical properties, provide a unique microenvironment for the selfrenewal and differentiation of
hESCs.
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Control of self-renewal and differentiation of human ES cells (hESCs)
remains a challenge. This is largely due to the use of culture systems
that involve poorly defined animal products and do not mimic the
normal developmental milieu. Routine protocols involve the propa-
gation of hESCs on mouse fibroblast or human feeder layers, enzy-
matic cell removal, and spontaneous differentiation in cultures of
embryoid bodies, and each of these steps involves significant vari-
ability of culture conditions. We report that a completely synthetic
hydrogel matrix can support (i) long-term self-renewal of hESCs in the
presence of conditioned medium from mouse embryonic fibroblast
feeder layers, and (ii) direct cell differentiation. Hyaluronic acid (HA)
hydrogels were selected because of the role of HA in early develop-
ment and feeder layer cultures of hESCs and the controllability of
hydrogel architecture, mechanics, and degradation. When encapsu-
lated in 3D HA hydrogels (but not within other hydrogels or in
monolayer cultures on HA), hESCs maintained their undifferentiated
state, preserved their normal karyotype, and maintained their full
differentiation capacity as indicated by embryoid body formation.
Differentiation could be induced within the same hydrogel by simply
altering soluble factors. We therefore propose that HA hydrogels,
with their developmentally relevant composition and tunable phys-
ical properties, provide a unique microenvironment for the self-
renewal and differentiation of hESCs.
scaffolds  three-dimensional cultures  vasculogenesis
Undifferentiated human ES cells (hESCs), derived from theinner cell mass of the developing blastocyte, are routinely
cultured onmouse embryonic fibroblast feeder layers (MEFs) or on
surfaces coated with Matrigel (an animal basement membrane
preparation extracted from Engelbreth–Holm–Swarm mouse sar-
coma), laminin, fibronectin, and human serum (1–4) in MEF-
conditioned medium. To induce hESC differentiation, cells are
enzymatically removed frommonolayers and recultured in the form
of embryoid bodies (EBs) on a stromal layer (5) or on extracellular
matrix (6, 7). In contrast, during early development, hESCs reside
and differentiate within a single 3D environmental milieu. The
standard hESC culture protocols are thus limited by the need for
cell transfer between the two different and completely separate
culture systems for cell renewal and differentiation, which causes
significant variability of culture conditions. We investigated the
possibility of designing a single culture system that wouldmimic the
early developmental milieu and allow the cells to switch between
differentiation states within the same culture setting.
During embryogenesis, inner cell mass cells are embedded in a
3D matrix, which regulates both their self-renewal and differenti-
ation (8, 9). To establish a single, controllable 3D culture system in
which hESCs can be maintained as undifferentiated cells and
differentiate in response to specific cues, we explored encapsulation
of hESC lines in hydrogel scaffolds (that we selected to mimic the
developmental milieu) composed of a biologically recognized mol-
ecule (that we identified studying the MEF cultures of hESCs).
Hydrogels not only have a high water content to promote cell
viability, but they are structurally and mechanically similar to the
native extracellularmatrix ofmany tissues (10). In combinationwith
recently developed chemically defined media (11), these scaffolds
could provide a defined system for hESC culture that does not
incorporate any animal components.
Several studies have explored the culture of hESCs in defined 3D
settings by using a variety of natural and synthetic scaffolds for cell
growth (12), differentiation (13), or lineage guidance (14–18).
There has been a considerable effort to replace more biological but
less controllable native materials with synthetic materials. The
synthetic scaffolding materials explored thus far have not been
designed by using developmentally relevant molecules and, in the
best case, supported only a short-term self-renewal of hESCs (12).
We hypothesized that hyaluronic acid (HA), a nonsulfated linear
polysaccharide of (1--4)D-glucuronic acid and (1--3)N-acetyl-D-
glucosamine, would support hESC growth in vitro, because it
coregulates gene expression, signaling, proliferation, motility, ad-
hesion, metastasis, and morphogenesis of hESCs in vivo (19). In
humans, the HA content is greatest in undifferentiated cells and
during early embryogenesis and then decreases at the onset of
differentiation (20), where it has a crucial role in regulation of the
angiogenic process (21–23). Despite its known role in embryogen-
esis (19, 20), HA has not been used for the cultivation of hESCs.
We suggest that HA-based hydrogels can maintain the
undifferentiated state of hESCs in the presence of conditioned
medium from MEFs until soluble factors are introduced to
direct cell differentiation. We found that hESCs have active
HA binding sites and receptors that are involved in feeder
layers and showed that hESCs are able to internalize and
process HA. We report that the cultivation of hESCs in HA
hydrogels maintained the state of cell self-renewal and enabled
EB formation from released cells, whereas the introduction of
angiogenic factors readily induced cell sprouting and elonga-
tion, indicating a switch to vascular differentiation.
Results and Discussion
HA Is Involved in the Maintenance of Undifferentiated hESCs.We first
investigated whether HA plays a role in conventional cultures of
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undifferentiated hESCs. We observed that MEFs, which form
feeder layers for hESC cultivation, produce 8-fold higher levels of
HA (840 ng/ml) compared with initial levels in the growth media
(105 ng/ml) and that abundant HA binding sites are located
intracellularly in undifferentiated hESCs (Fig. 1A). These findings
are consistent with previous evidence that HA is localized intra-
cellularly, in endosomes and perinuclear tubular vesicles, rough
endoplasmic reticulum, nuclei, and nucleoli (24–26). We therefore
investigated whether the success of MEF feeder layers for the
cultivation of hESCsmight be related to their ability to secrete HA.
During development, cellular interactions withHA aremediated
by CD44 and CD168. CD44 is a mediator for HA-induced cell
proliferation and survival pathways (19) and is present in human
cumulus cells, oocytes, early embryos, and prehatched blastocysts
(27). CD44 also is involved in the initial binding of HA to the cell
surface before its internalization and degradation by acid hydroly-
sis. CD168 is involved inHA-induced cell locomotion (28) and early
embryos (29). During in vitro culture, undifferentiated hESCs
expressed high levels of CD44 and CD168 (Fig. 1B). In fact, hESC
colonies cultured onMEFs could be easily visualized by staining for
CD44 (Fig. 1Ci) or CD168 (Fig. 1Cii). Confocal analysis suggests
that CD44 is expressed intracellularly (Fig. 1Ciii) and CD168 is
expressed either on the membrane or intracellularly in undifferen-
tiated cells (Fig. 1Civ).
The addition of human fluorescein-labeled HA (FL-HA) to the
culture of hESCs on MEFs resulted in the localization of HA
receptors to the cell membranes, first at the edges of cell colonies
and then at their centers (Fig. 2A). FL-HA was observed to be
internalized (Fig. 2Bi) and localized within the cells (Fig. 2 Bii and
Biii). No internalization of FL-HA could be observed once anti-
CD44 was added to the cultures of hESCs, indicating receptor-
mediated internalization of HA by hESCs. To examine whether
blocking HA internalization effects self-renewal, hESCs were pas-
saged and seeded on MEFs with and without the addition of a
mixture of anti-CD44 (clones A3D8 and P3H9) and anti-CD168.
After 24 h, colony formation could be observed in both culture
conditions.However, fewer colonies (32.5 3.41 vs. 59.2 8.35 per
well) and a higher differentiation rate (43.66 0.046% vs. 12.75
0.033%) (Fig. 2C) were observed in the cultures supplemented with
antibodies. After 48 h, the antibody-containing cultures still had
much lower colony numbers (37.75 7.0 vs. 101.5 9.2) and higher
differentiation rates (34.5  0.047% vs. 5.93  0.005%) (Fig. 2C)
than control cultures. This result further suggests that HA recep-
tors, CD44, and CD168 are involved in the self-renewal of hESCs.
Immunofluorescence of hESC colonies cultured onMEFs revealed
that densely packed colonies expressed human hyaluronidase Hyal
1 and 2 (Fig. 2D). RT-PCR analysis corroborated that hESCs
express high levels of Hyal 2, one of the isoforms of human
hyaluronidase (Fig. 2E). It was previously suggested that HA
originates from the pericellular material that is degraded intracel-
lularly (30, 31). Our data suggest that hESCs are able to uptake and
degrade HA and thereby remodel HA gels, a feature necessary for
cell survival and migration.
HA Hydrogels Provide a Biocompatible Environment for hESC Culture.
Rather than adding soluble HA to the culture or modifying
biomaterial surfaces with this molecule, we chose to more directly
mimic the native environment and encapsulate hESCs in hydrogels
fabricated entirely of HA. To accomplish this, HA was modified
with photoreactive groups (32) and colonies of hESCs were sus-
pended in a solution of themodifiedHA and photoinitiator in PBS.
This process has been used previously to entrap a variety of
mammalian cells (33). In our previous studies, hydrogels comprised
of 2 wt% of a 50-kDa macromer supported the highest viability of
differentiatedmammalian cells (32, 33) and thus were used in these
studies. One advantage ofHAhydrogels is that the chemistry of the
network is easily controlled through reaction conditions and is
uniform between the various batches (32), which is difficult or
impossible to achieve with naturally derived matrices such as
Matrigel. Additionally, the monomer is obtained microbially and
does not introduce animal components.
Because hESCs are particularly susceptible to harmful culture
conditions (34), it was important to assess any toxicity of the
methacrylated HA macromer. Human ESCs were propagated in
monolayers with a range of concentrations of theHAmacromer (0,
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Fig. 1. HA plays a role during hESC culture on MEFs. (A) Staining of hESCs (H1
line) grown on MEFs for HA binding site (green), undifferentiated membrane
marker TRA-1–81 (red), and nuclei (blue): Intracellular localization of HA (Ai
andAii), including perinuclear areas (arrows) (Aiii) and nuclei (*), and nucleoli
(arrowheads) (Aiv). (B) FACS analysis revealed that compared with isotype
control (Left), the majority of undifferentiated hESCs were found to express
HA receptors CD44 (82%) (Center) and CD168 (90%) (Right). (Ci and Cii) By
using immunofluorescence staining, undifferentiated hESC colonies were
easily detected with undifferentiated cell markers Oct4 (green) and CD44 or
CD168 (red), respectively (nuclei: blue). (Ciii and Civ) Higher magnification
suggests intracellular expression of CD44 and either membrane or intracellu-
lar expression of CD168. (Scale bars: Ai, Aii, Ci, and Cii, 100 m; Aiii, Ciii, and
Civ, 25 m; Aiv, 10 m.)
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10, and 50 l/ml culture medium). Human ESCs formed colonies
of proliferating cells at all culture conditions (Fig. 3 Ai–Aiii).
Comparison of the metabolic activity rates revealed slight toxic
effects only at the macromer concentration of 50 l/ml (Fig. 3Aiv),
a level corresponding to completely nonpolymerized HA and
thereforemuch higher than that seen by the encapsulated cells. The
rate of cell proliferation at a macromer concentration of 10 l/ml,
a level corresponding to a HA hydrogel that was polymerized to
80% incorporation of the macromer, was indistinguishable from
that in control medium (Fig. 3 Aiv and Av). Radical polymerization
of loosely cross-linked HA hydrogels occurs at high conversion
rates and the release of unreacted macromer is only minimal, thus
minimizing any toxicity that may result from the presence of free
HA macromer.
Because formation of HA gels involves exposure to low levels of
UV light, we explored potential DNA damage to the hESCs during
this process. A recent study demonstrated that hESCs express low
levels of p53 (compared with mESCs) and that long-term exposure
(5 h) to UV light resulted in accumulation of p53 in the cell nuclei
(35). Accumulation of p53 could be observed 12 h after exposure
to UV (35). We therefore explored whether 10 min of exposure to
UV light results in accumulation of p53 in hESCs. We found that
p53 accumulated in cells exposed to UV light for 5 h, whereas only
background levels of p53 expression were detected in both unex-
posed cells and those exposed to 10 min of UV light (Fig. 3B). This
result suggests that photopolymerization of hESCs in HA macro-
mer does not directly damage their DNA.
HA Hydrogels Maintain hESCs in Their Undifferentiated State of
Self-Renewal. For encapsulation, hESCs were suspended in a solu-
tion of HA macromer and photoinitiator and photopolymerized
into a hydrogel network, and constructs were placed within con-
ditioned medium supplemented with basic FGF. Human ESCs
encapsulated in the HA hydrogels were uniformly distributed
throughout the gel (Fig. 3C), forming cell colonies with a range of
sizes (Fig. 3D). The cells retained metabolic activity (Fig. 3E) and
early doubling times of36 h, comparable with those in 2D culture
systems (34) for up to 5 days, as determined by a 2,3-bis(2-methoxy-
4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) as-
say (Fig. 3F). As the cells remodeled the hydrogel, colonies near the
surface were released, making it difficult to accurately quantify cell
proliferation.Wedocumented themaintenance of hESC viability in
HA hydrogels through several markers. The human Ki-67 protein,
which is associated with cell proliferation, was expressed by the
majority of encapsulated hESCs after 20 days of culture (58 5%)
[supporting information (SI) Fig. 6A]. Only occasional apoptotic
events could be observed by using a Tunnel assay (14 3%). These
results correlate to a recent study that showed that50%of the cell
nuclei within hESC colonies grown on MEFs are in a proliferating
phase (36). Only infrequent expression of caspase-3, a marker
activated in cells undergoing apoptosis, was foundwithinHA-hESC
constructs (3  8%) after 20 days of culture. When detected,
caspase-3 appeared in a whole colony rather than in single cells
within different colonies (SI Fig. 6 B and C) and only in cultures
older than 15 days. Therefore, under the conditions studied,
diffusion of nutrients and oxygen to the cells through the 2wt%HA
hydrogel appeared to be rapid enough to support normal cell
growth rates. In addition, the cells maintained their typical undif-
ferentiated morphology of colonies within the HA networks (Fig.
3G) after 20 days in culture. High cell concentrations, in the range
of 5–10  106 cells per milliliter of the precursor solution, were
essential for high viability and sustained cell growth. At hESC
concentrations greater than 10  106 cells per milliliter, large
clumps of cells formed that underwent rapid apoptosis, whereas cell
concentrations lower than 5  106 cells per milliliter could not
support colony formation within the networks (data not shown).
The same phenomenon of concentration dependence of hESC
colony formation was observed in 2D monolayers (37, 38).
To determine whether the hESC-HA interactions, and not only
the 3D morphology via encapsulation in hydrogel, are critical for
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Fig. 2. HA interaction with hESCs. (A) Localization of HA receptors in response to addition of human FL-HA to the growth medium of hESCs (H9 line) cultured on
MEFs. (Ai andAii) Confocal analysis suggests relocalization of HA receptors in cell membranes of both CD44 (Ai) and CD168 (shown in red, nuclei shown in blue) (Aii).
(Aiii and Aiv) Higher magnification of CD168 localization is shown with (Aiii) and without (Aiv) the addition of human HA. (B) HA uptake by hESC (H9 line) colonies.
Undifferentiated hESCs (H1 line) grown on MEFs were incubated overnight with fluorescein-HA and further stained for CD44 and CD168. (Bi) Edge of colony suggests
internalizing FL-HA via CD44. (Bii andBiii) Intracellular localization of FL-HA. (C) Seeding of hESCs (H9 line) in the presence of anti-CD44 and CD168 resulted in less and
differentiated colonies (both at the edge and center of the colonies, as indicated by arrows and asterisks, respectively), whereas control cultures contain expanding
undifferentiated colonies. (D) Human ESC (H13 line) colonies grown on MEFs positive for Oct4 (green) express Hyal 1 (Di) or Hyal 2 (Dii) (red; nuclei are shown in blue)
mainly in densely packed areas of the colonies. (E) RT-PCR analysis revealed high expression levels of a hyaluronidase isomer, Hyal 2, in undifferentiated hESCs (H9 line).
PC3 line served as positive control. (Scale bars: 100 m.)
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controlled hESC differentiation, hESCs were also encapsulated in
networks formed from a different polysaccharide, dextran, using
the exact samemethodology of photopolymerization. In contrast to
the maintenance of undifferentiated hESC colonies in the HA
system, dextran hydrogels induced hESC differentiation and the
formation of EBs (Fig. 3H). These results are consistent with data
published for other hydrogel systems that also supported hESC
differentiation (14, 18, 39). Therefore, HA hydrogels act as a
unique microenvironment for the propagation of hESCs, likely due
to the regulatory role of HA in the maintenance of hESCs in their
undifferentiated state, in vitro as well as in vivo.
Human ESCs Released from HA Hydrogels Are Viable and Undifferen-
tiated, and Have Preserved Genetic Integrity. To enable the use of
HA hydrogels for research and cellular therapy, the cells need to be
released from the hydrogel with preservation of high viability. This
can be achieved by treatment with hyaluronidase (32). First, hESCs
were examined for their viability during a long-term treatment (i.e.,
24 h). Human ESC colonies incubated with growth medium
containing 100–2,000 units/ml hyaluronidase preserved their nor-
mal morphology with no apparent loss of viability (Fig. 4 A–D).
Incubation of HA-hESC constructs in growth medium containing
2,000 units/ml hyaluronidase resulted in complete degradation of
the hydrogel (Fig. 4 E and F). We also found that the viability of
hESCs incubated with 2,000 units/ml hyaluronidase for 24 h was
comparable with that measured for incubation with 1 mg/ml
collagenase IV for 30 min (76.5 8% vs. 70 4.5%, respectively).
In contrast, hyaluronidase concentrations of 1,000 units/ml re-
sulted in only partial degradation of HA hydrogels over a 24-h
period and were associated with low efficiency of hESC retrieval.
Importantly, the release of hESCs from the HA hydrogels was
associated with the full preservation of cell viability and undiffer-
entiated state. Colonies released from the hydrogels readily ad-
hered toMEFs (Fig. 4G) with high adherence efficiency (79 2.5%
after 48 h) and proliferated at rates normally seen in standard
monolayer cultures (Fig. 4H). Furthermore, FACS analysis of
released hESCs showed high levels of expression of stem cell
markers SSEA4 and alkaline phosphatase (Fig. 4I).
The proposed system for hESC culture in an HA hydrogel
involves the exposure of hESCs to low-intensity UV light (i.e.,10
mW/cm2 for 10 min) and treatment with hyaluronidase (i.e., 2,000
units/ml for 24 h). Because these factors could potentially affect the
genetic integrity of hESCs, karyotype analysis was performed on (i)
undifferentiated hESCs cultured on MEFs (H9 line p22 and H13
line p25); (ii) undifferentiated hESCs cultured on MEFs (H9 line
p22 and H13 line p25), all of which were exposed to UV light for
10min; (iii) undifferentiated hESCs cultured onMEFs (H9 line p22
and H13 line p25) treated with hyaluronidase (2,000 units/ml) for
24 h; (iv) undifferentiated hESCs (H9 line p38) encapsulated inHA
gels for 5 days followed by their release and reculture on MEFs for
an additional three passages; and (v) H13 p33 encapsulated in HA
for 2 weeks and recultured onMEF for two passages. HumanESCs
were found to have normal karyotype with no clonal aberration
(SI Fig. 7). Hence, the application of UV light, encapsulation, and
Fig. 3. HA hydrogels support the maintenance of viable hESCs in their undifferentiated state. (Ai–Aiv) Undifferentiated hESCs (H9 line) were passaged and
recultured on feeder layers for 4 days in culture medium containing: no macromer (Ai), 10 l/ml macromer (corresponding to the hydrogel containing 80%
nonpolymerized monomer) (Aii), or 50 l/ml macromer (corresponding to completely nonpolymerized monomer) (Aiii). Toxic effects were detected only at the
macromer concentration of 50 l/ml. (Aiv andAv) XTT assay (Aiv) and cell count (Av) revealed no negative effect of macromer on cell viability at a concentration
of 10 l/ml and a slight decrease in hESC viability at a macromer concentration of 50 l/ml. Results are presented as means SD (*, P 0.05). (B) Low basal levels
of p53 are expressed by hESCs (H13 line) 12 h postincubation after 10 minutes of UV exposure, whereas accumulation of p53 in hESCs was observed 12 h
postincubation after 5 h UV exposure. (C and D) Light microscopy revealed uniform distribution of hESC colonies in HA gels (C) with a range of colony sizes (D).
(E) Incubation with XTT revealed orange dye in metabolically active hESCs (H13 line) encapsulated in HA hydrogels. (F) XTT assay shows comparable growth rates
of hESCs encapsulated in HA hydrogels and on Matrigel. (G) A representative histological section of hESC-HA constructs (H9 line) cultured for 20 days
demonstrates uniform morphology (H&E stain) of undifferentiated colony within 3D networks (folding of the hydrogel is indicated by an asterisk). (H)
Encapsulation of hESCs (H13 line) in HA hydrogels was compared with dextran hydrogels after 15 days of culture. Light microscope images of both cultures at
low and high magnifications and histological sections (H&E stain) demonstrate EB formation in dextran hydrogels vs. colony arrangements of undifferentiated
hESCs in HA hydrogels. (Scale bars: A, C–F, and H, 100 m; B and G, 25 m.)
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hyaluronidase at the levels necessary for our work appear to be safe
for hESCs.
Human ESCs Encapsulated in HA Hydrogel Maintain Their Capacity for
Differentiation.An important advantage of theHAhydrogel system
is that the hESCs can be first maintained in their undifferentiated
state and then exposed to differentiation factors within the same
system or released to be studied with other strategies, in vitro or in
vivo. To illustrate this feature, we compared (i) spontaneous
differentiation of hESCs viaEB formation for hESCs released from
hydrogel and (ii) induction of vasculogenic sprouting of HA-
encapsulated hESCs. Cells that were cultured in HA hydrogels for
30 days, released with hyaluronidase, and subsequently cultured in
suspension were found to form EBs containing cell types repre-
sentative of all three germ layers (SI Fig. 8). HA was observed to
play a role in the regulation of angiogenesis and vascular endothelial
cell function. In particular, low-molecular-weight degradation prod-
ucts (3–10 disaccharide units) stimulated endothelial cell prolifer-
ation, migration, and sprouting (22). Generation of ‘‘angiogenic’’
HA from the naturally occurring HA is mediated by the endogly-
cosidase hyaluronidase, by processes that are associated with tissue
damage, inflammatory disease, and certain types of tumors (21).
We therefore explored HA hydrogel culture systems for vascular
differentiation. Human ESCs were encapsulated in HA hydrogels
and cultured in MEF conditioned medium for 1 week, after which
the medium was replaced by angiogenic differentiation medium
containing VEGF. Cell sprouting and elongation was observed
after 48 h for hESC colonies treated with VEGF (Fig. 5 A and B).
After 1 week of differentiation, staining with specific vascular
markers revealed that most sprouting cells were positive for smooth
muscle actin (Fig. 5C), whereas few were positive for CD34
(Fig. 5D).
Materials and Methods
hESCs. Multiple lines of hESCs were studied: H9, H13, and, in
several studies, H1 (WiCell Research Institute, Madison, WI).
hESC Culture on MEFs. hESCs were grown on inactivated MEFs in
growth medium consisting of 80% knockout DMEM, supple-
mentedwith 20%knockout serum replacement, 4 ng/ml basic FGF,
1 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 1% nonessential
amino acid stock (Invitrogen). Human ESCs were passaged every
4–6 days with 1 mg/ml type IV collagenase (Invitrogen).
hESC Encapsulation and Release.MethacrylatedHAwas synthesized
as described (32) (SI Materials and Methods). It was dissolved at a
concentration of 2 wt% in PBS containing 0.05 wt% 2-methyl-1-
[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959),
and hESCs were added [(0.5–1)  107 cells per milliliter of
precursor solution]. The mixture was pipetted into a sterile mold
A B C D
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0.13% 0.13%
2.62%
0.00% 0.15%
76.94%
74.93% 0.00%
0.00%
1.81% 0.00%
0.00%
I
Fig. 4. Cell release from hydrogels and cell karyotyping. (A–D) hESCs (H13 line) grown on MEFs were incubated for 24 h in growth medium (A), 1% collagenase
solution in growth medium (B), 1,000 units/ml hyaluronidase solution in growth medium (C), and 2,000 units/ml hyaluronidase solution in growth medium (D).
To release hESCs from HA hydrogel, constructs were incubated with 2,000 units/ml hyaluronidase in growth medium. (E) After 18 h, small particles of hydrogels
remained that trapped hESCs. (F) After 24 h, hESCs colonies were completely released from the hydrogel. (G and H) hESCs (H9 line) released from the hydrogel
after 30 days of encapsulation and cultured on MEFs formed small colonies of undifferentiated cells after 24 h (G) and were propagated on MEFs for three
passages (H). (I) FACS analyses of released cells after 20 days of HA culture revealed high levels of SSEA4 and alkaline phosphatase. (Scale bars: 100 m.)
B DA C
Fig. 5. Differentiation. H9 line cells were cultured in conditioned medium for 1 week followed by the replacement of medium containing VEGF. (A and
B) Cell sprouting was observed after 48 h in gels transferred to medium containing VEGF (arrows) (A) compared with gels continuously cultured in
conditioned medium (B). (C and D) After 1 week of differentiation, sprouting elongating cells were mainly positive for vascular -smooth muscle actin (C),
whereas some were positive for early stage endothelial marker (D). CD34 (in situ 3D staining of gels). (Scale bars: A and B, 100 m; C and D, 25 m.)
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(50-l volume per well, to obtain discs with diameters of 3 mm and
thicknesses of 2 mm) and photopolymerized [10 mW/cm2 UV
light (BlakRay) for 10 min]. The acrylated dextran macromer was
prepared as described (18) (SI Materials and Methods), and hESCs
were encapsulated within the dextran by using the same procedures
as for HA hydrogels. Cell–gel constructs were cultivated in MEF
conditioned medium as previously described (2). For differentia-
tion, gels were cultured with endothelial growth medium (Cam-
brex) supplemented with 100 ng/ml VEGF (R & D Systems).
To release encapsulated hESCs, HA constructs were incubated
for 24 h in hESC growth medium containing 100, 500, 1,000, or
2,000 units/ml hyaluronidase (Sigma). The percentage of viable
hESCs incubated with 2,000 units/ml HAase for 24 h or 1 mg/ml
collagenase IV for 30 min was examined by trypan blue. For
reculture, cells were collected, centrifuged, washed three times with
PBS to remove any hydrogel residues, resuspended in growth
medium, and cultured onMEF-coated dishes according to standard
methods (35, 36). For adherence studies, released hESC colonies
were seeded on four-well plates coated withMEFs and themedium
was not changed for 48 h. To estimate the adherence percentage,
we collected the media from each well and counted the colonies in
the supernatant and those that attached to theMEFs.We excluded
single cells from the counts. Results are presented for n  3. For
EB formation, released hESCs were recultivated in nonadherent
Petri dishes with EB medium (13).
Presence of HA in Medium.MEF-conditionedmediumwas prepared
as described (2) and compared with hESC growth medium with
respect to the levels of HA by using an HA test kit (Corgenic).
FACS Analysis. hESCs were removed from MEFs or released from
hydrogels and analyzed by means of flow cytometry (SI Materials
and Methods).
Proliferation Assay. Cell proliferation was detected either by daily
cell count or the XTT kit (Sigma) according to the manufacturer’s
instructions (SI Materials and Methods).
Immunohistochemistry. EBs andHA constructs were either embed-
ded in histo-gel or directly fixed in 10% neutral-buffered formalin
(Sigma) overnight, dehydrated in graded alcohols (70–100%),
embedded in paraffin, sectioned to 4 m, and either stained with
hematoxylin eosin or immunostained with specific markers (SI
Materials and Methods).
Immunofluorescence and Confocal Microscopy. hESC colonies grown
on MEFs, hESC colonies grown on MEFs and exposed to UV for
10 min and 5 h, and HA-hESC-differentiated constructs were fixed
in situ with Accustain (Sigma) for 20–25 min at room temperature.
After blocking with 5% FBS, cells were permeabilized (when
intracellularmarkers were examined) and stained with one primary
antibody (see list of antibodies in SI Materials and Methods). Cells
were then rinsed three times with PBS (Invitrogen) and incubated
for 30min with suitable FITC- (R&DSystems) or Cy3-conjugated
(Sigma) secondary antibodies. DAPI (2 g/ml; Sigma) or To-pro 3
(1:500; Molecular Probes/Invitrogen) were added during the last
rinse. IgG isotype-matching using mouse or goat (both from R &
D Systems) or secondary antibody alone served as controls. The
immunolabeled cells were examined by using either fluorescence
microscopy (TE300 inverted microscope; Nikon) or confocal laser
scanning microscopy (LSM 510; Zeiss).
HA Binding, Uptake, and Blocking. The binding assay of FL-HA was
performed as described (26). Briefly, hESCs were cultured on
coverslips and gently washed. Human FL-HA at 100g/ml (Sigma)
was added to the growth medium for 16 h at 4°C. In some cases, to
study the role HA receptor, anti-human CD44 was added to the
cultures or incubation with FL-HA. After three washes with
ice-cold PBS, the cells were fixed in 100% ice-cold acetone for 10
min, air-dried, and rehydrated for 15 min in PBS. Processed cells
were further stained with anti-CD44 or anti-CD168 and examined.
To block HA receptors, hESCs were passaged and seeded with or
without the addition of a mixture of anti-CD44 (clones A3D8 and
P3H9) and anti-CD168 (n  4). Colony formation and morpho-
logically differentiating colonies were quantified and documented
after 24–48 h.
RT-PCR. RNA was extracted and analyzed as described (40). Please
see SI Materials and Methods for details.
Karyotyping Analysis. Cells were prepared and analyzed as de-
scribed and recommended (41). Please see SI Materials and Meth-
ods for details.
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